drugset / Trial / NCT00793000
Safety And Pharmacokinetics Study Of PF-04287881 In Healthy Adults
RandomizedParallel-groupDouble-blind
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of PF-04287881 after a single oral dose in healthy adult volunteers.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-12
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-04287881 | Unknown | 75 mg | Oral |
| Subject | PF-04287881 | Unknown | 150 mg | Oral |
| Subject | PF-04287881 | Unknown | 300 mg | Oral |
| Subject | PF-04287881 | Unknown | 750 mg | Oral |
| Subject | PF-04287881 | Unknown | 1000 mg | Oral |
| Subject | PF-04287881 | Unknown | 1250 mg | Oral |
| Subject | PF-04287881 | Unknown | 1500 mg | Oral |